<DOC>
	<DOCNO>NCT00372775</DOCNO>
	<brief_summary>This study evaluate safety , tolerability efficacy SU011248 patient non-small cell lung cancer brain metastasis .</brief_summary>
	<brief_title>Study Tests The Safety And Effectiveness Of SU011248 In Patients With Non-Small Cell Lung Cancer Having Brain Metastases</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Sunitinib</mesh_term>
	<criteria>Patients radiologically proven brain metastasis secondary nonsmall cell lung cancer Received previous whole brain radiation therapy none , 1 2 prior systemic therapy treatment advanced/metastatic nonsmall cell lung cancer Patients brainstem lesion , spinal cord compression . carcinomatous meningitis , leptomeningeal disease . Brain metastases &gt; 4 cm linear direction Intracranial intratumoral hemorrhage</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>brain metastasis</keyword>
	<keyword>Sunitinib</keyword>
	<keyword>Phase 2</keyword>
</DOC>